Subscribe now

IN 2001, Viagra earned Pfizer a cool $1.5 billion. Not surprisingly, the company would like to sell its little blue pill to women as well as men, and envious competitors are keen to develop their own Viagra-like products for women.

But there’s a problem. Women do not suffer the same physical problems with sex as men, and you cannot market a drug unless there is an accepted clinical need for it. So what’s a company to do? Answer: invent a condition called “female sexual dysfunction” and persuade experts to claim a whopping 43 per cent of women suffer from it at some time.…

Sign up to our weekly newsletter

Receive a weekly dose of discovery in your inbox. We'll also keep you up to date with New Scientist events and special offers.

Sign up

To continue reading, subscribe today with our introductory offers

Popular articles

Trending New Scientist articles

Piano Exit Overlay Banner Mobile Piano Exit Overlay Banner Desktop